etilefrine has been researched along with Migraine Disorders in 1 studies
Etilefrine: A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The number of attacks of migraine was significantly reduced after the 3-month treatment with Ep resp." | 2.66 | [Double blind study of migraine therapy with etilefrine pivalate]. ( Bühling, M; Cruz, A; Seibel, K, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cruz, A | 1 |
| Bühling, M | 1 |
| Seibel, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Efficacy and Mechanisms of Change of Compassion Cultivation Training in Medical Students[NCT04690452] | 40 participants (Actual) | Interventional | 2020-12-11 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for etilefrine and Migraine Disorders
| Article | Year |
|---|---|
[Double blind study of migraine therapy with etilefrine pivalate].
Topics: Adult; Aged; Clinical Trials as Topic; Dihydroergotamine; Double-Blind Method; Etilefrine; Female; H | 1985 |